About 12,000 bacteria and viruses collected in a sampling from public transit systems and hospitals around the world from 2015 to 2017 had never before been identified, according to a study led by Weill Cornell Medicine investigators.
Twenty seniors in the Milstein Program in Technology & Humanity will graduate this year with degrees in everything from biology to linguistics to computer science to physics.
Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.
Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.
A decline in New York’s childbirth rate is showing no sign of reversing and many women are waiting longer to have children, according to newly compiled data from the Program in Applied Demographics in the Cornell Jeb E. Brooks School of Public Policy.
Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.
After losing his mother to breast cancer, Ryan Nowicki '16 crowdfunded for a novel cancer treatment that had once piqued the interest of his mother at Cornell.
The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart’s rhythmic beat, setting off a self-destruction process within the cells, according to a preclinical study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and NYU Grossman School of Medicine.
Finding innovative solutions for cities’ most pressing problems is a primary goal of the new Urban Tech Hub, part of the Jacobs Technion-Cornell Institute at Cornell Tech.